Patent · US Active

Compounds

US8097628B2 · kind B2 · utility

1Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2009
Grant dateJan 17, 2012
Priority date—
Expiry dateFeb 20, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides thereof:(relative chemistry shown) pharmaceutical compositions comprising them, their use in therapy especially against tuberculosis, and methods of preparing them are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.